Communiqués GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Marché Fermé - London S.E. Autres places de cotation 17:35:22 13/06/2025			Varia. 5j.	Varia. 1 janv.
1 511,50 ^GBX	-2,45 %		-0,10 %	+12,25 %

13/06	Moderna chute en raison des craintes que le nouveau comité consultatif sur les vaccins du CDC ne compromette les perspectives du vaccin contre le VRS	RE
13/06	Les Bourses chutent, le pétrole s'envole après les frappes israéliennes contre l'Iran	AN

Communiqués

GSK : RSV vaccine, Arexvy, accepted for regulatory review by the European Medicines Agency to expand use in adults 18 years and older	13/06	PU
GSK Plc - Director/PDMR Shareholding	12/06	PR
GSK : licenses Shigella vaccine candidate to Bharat Biotech for continued development	12/06	PU
GSK : data at ASCO and EHA showcase latest research and innovation across the oncology portfolio	29/05	PU
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee	28/05	AQ
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)	22/05	BU
GSK : Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)	22/05	PU
GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis	09/05	BU
GSK : GLISTEN phase III trial results show linerixibat significantly improves cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC)	08/05	PU
GSK : continues to advance the future of respiratory medicine and patient care with new data at ATS	02/05	PU
GSK : Nucala (mepolizumab) delivers clinically meaningful and statistically significant reduction in COPD exacerbations, with positive MATINEE trial results published in New England Journal of Medicine	30/04	PU
Glaxo: Q1 Earnings Snapshot	30/04	AQ
GSK : makes strong start to 2025 with growth in sales, profits and earnings	30/04	PU
GSK : Blenrep (belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple myeloma	17/04	PU
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices	16/04	BU
GSK : Arexvy recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices	16/04	PU
GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices	16/04	BU
GSK : 5 in 1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices	16/04	PU
Investing in the $532B Oncology Boom: Key Stocks Shaping the Future of Cancer Treatment	11/04	AQ
Barbara Weber, M.D., Elected to ITM Supervisory Board	10/04	AQ
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025	09/04	BU
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm	07/04	BU
GSK DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GSK plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GSK	04/04	NE
Deadline Soon: GSK plc. (GSK) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit	04/04	BU
GSK Deadline: Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights	03/04	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

GSK PLC : malgré les défis auxquels elle est confrontée, GSK reste une valeur intéressante pour les investisseurs.

Le 21 mai 2025 à 16:08

Le PDG de GSK parle de l'expansion aux États-Unis, des fusions et acquisitions, du portefeuille de médicaments et de Trump

Le 13 janvier 2025 à 21:03

GSK plc : Reprend des couleurs

Le 03 mai 2024 à 11:03